Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Genistein in Advanced Solid Tumors and NSCLC
NCT01628471Phase 2Completed
- Sponsor
- Uman Pharma
- Start
- Nov 2012
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine, genistein in solid tumor, non-small cell lung cancer (NSCLC), sponsored by Uman Pharma. Started Nov 2012; status: completed.
02
Drugs
decitabinegenistein
03
Conditions
solid tumornon-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01628471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628471.